profit from every $100 of sales.
$0$100
Outset Medical
$3.86-7.43% today
-30.3% in 1 year
1-year low $2.961-year high $5.68
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Outset Medical sold, what it kept, and what it did with the cash.
Sales went from $115 million in 2022 to $119 million in 2025, with -$81.7 million of profit last year.
SalesProfit
Outset Medical vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Outset Medical | No profit yet | ||
 Boston Scientific | 22.1× · Fair price | ||
 Koninklijke Philips | 29.7× · Fair price | ||
 Steris | 31.5× · Expensive | ||
 Zimmer Biomet Holdings | 28.1× · Fair price |
AI analysis
An AI analyst reads Outset Medical's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 115 | 130 | 114 | 119 | |
| 18 | 29 | 39 | 47 | |
| -161 | -170 | -113 | -67 | |
| -154 | -154 | -98 | -63 | |
| -163 | -173 | -128 | -82 | |
| -50.70 | -52.20 | -36.90 | -5.37 | |
| 15.5% | 22.2% | 33.9% | 39.1% | |
| -139.6% | -130.2% | -99.7% | -55.8% | |
| -141.2% | -132.5% | -112.6% | -68.3% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 400 | 314 | 276 | 264 |
| Cash | 73 | 69 | 124 | 35 |
| Total debt | 103 | 136 | 202 | 101 |
| Total liabilities | 154 | 191 | 249 | 138 |
| 246 | 123 | 27 | 127 | |
| 3 | 3 | 3 | 15 | |
| -36.0% | -48.7% | -35.8% | -23.2% | |
| -66.2% | -140.6% | -477.2% | -64.3% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -146 | -131 | -116 | -46 | |
| 8 | 3 | 1 | 1 | |
| -154 | -135 | -117 | -47 | |
| Dividends paid | – | – | – | – |
| – | – | – | – | |
| 27 | 39 | 29 | 16 |
Valuation
- –
- –
- –
- 0.6×
- 0.6×
- –
- –
- -64.7%
- -112.1%
- 0.0%
Profitability
- 39.1%
- -55.8%
- -68.3%
- -53.3%
- -31.3%
- -47.3%
- -55.9%
- -30.0%
- -31.6%
- 18.1%
Growth
- +1.2%
- –
- +59.8%
- –
- +49.6%
Financial health
- –
- 0.04
- 1.9%
- -9.5×
- 6.29
- 4.97
- 0.47
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 15%of 952
Bottom 6%of 883
Bottom 17%of 870
Bottom 1%of 985
What analysts expect
- Average price target
- $10.00
- Range
- $7.00 – $15.00
- 1 analysts
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 7, 2026 | -0.83 | -0.79 | −5.1% |
| Feb 11, 2026 | -0.84 | -0.67 | −24.7% |
| Nov 10, 2025 | -0.69 | -0.66 | −5.3% |
| Aug 6, 2025 | -0.84 | -0.98 | +14.5% |
| May 7, 2025 | -3.24 | -0.95 | −242.9% |
| Feb 19, 2025 | -5.55 | -6.20 | +10.5% |
| Nov 6, 2024 | -5.85 | -0.40 | −1,362.5% |
| Aug 7, 2024 | -7.05 | -6.69 | −5.3% |
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
25No pass
Benjamin Graham
77Pass
Philip Fisher
22No pass
Peter Lynch
30No pass
Joel Greenblatt
0No pass
Charlie Munger
27No pass
Terry Smith
22No pass
Questions about Outset Medical
Is Outset Medical a good stock to buy?
A business with weak numbers that is not profitable yet. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Outset Medical AI analysis
What does Outset Medical do?
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It is in Medical - Devices.
Does Outset Medical pay a dividend?
No. Outset Medical does not pay a dividend at the moment.
Is Outset Medical stock halal?
No. Outset Medical does not pass our halal screen: its debt is 139% of its market value, at or above the 33% limit. How we check
How has Outset Medical stock done over the past year?
Down 30.3% over the past twelve months, to $3.86. It traded between $2.96 and $5.68 and is 32.0% below its high.
Who are Outset Medical's competitors?
The largest listed companies in the same industry are Boston Scientific, Koninklijke Philips, Steris and Zimmer Biomet Holdings. The peers table on this page compares their profit, growth and price with Outset Medical's.
Prices: daily closes to Nov 12, 2026. Fundamentals: company reports via invest-like data.